Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Imaging Biomarker Links Breast Tumor Heterogeneity to Targeted Therapy Response

By HospiMedica International staff writers
Posted on 04 Nov 2026

Breast cancer patients can respond differently to targeted therapy, even when their tumors appear similar on conventional imaging. More...

This variability can expose some patients to treatments that provide limited benefit while still causing toxicity, particularly in high-risk, early-stage disease treated before surgery. To improve treatment selection, researchers have developed an imaging biomarker designed to identify patients more likely to respond to AKT inhibition.

Researchers at The Hong Kong Polytechnic University developed the Tumour Heterogeneity Index (THI) to noninvasively assess likely treatment response before therapy begins. THI uses data from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), which is already widely used in breast cancer diagnosis and treatment planning. The method applies advanced radiomics to detect subtle imaging features that may not be apparent through conventional visual assessment.

The study evaluated patients with high-risk, early-stage breast cancer who received the investigational AKT inhibitor MK2206 in combination with neoadjuvant chemotherapy before surgery. The AKT/mTOR/PI3K signaling pathway plays an important role in tumor growth and survival and is a major target in cancer therapy. MK2206 had previously improved pathological complete response in the I-SPY2 clinical trial, although treatment response varied across aggressive subtypes including HER2-negative, hormone receptor-negative, and triple-negative breast cancer.

THI outperformed conventional immunohistochemistry-based receptor testing in identifying patients more likely to benefit from AKT inhibitor therapy. The index also provided information about the tumor microenvironment by assessing immune-cell characteristics and vascular features surrounding the tumor. Patients with high THI had an estimated pathological complete response rate of up to 56.1%, significantly higher than that observed in patients with low THI.

The findings were published in Breast Cancer Research. The team also developed DCE-MRI Vascularisation-based Response Tracking, or DCE-VASC-TRACK, for longitudinal monitoring of tumor vasculature during treatment. The model combines repeatable vascular texture features associated with pathological complete response at surgery with hormone receptor status, age, baseline functional tumor volume, and mid-treatment changes in functional tumor volume. The DCE-VASC-TRACK findings were published in Radiology: Artificial Intelligence.

“This challenge highlights the importance of accurately predicting treatment response before therapy begins. Our study presents an effective strategy for identifying patients who are most likely to benefit from treatment, with the potential to enhance the clinical value of drugs that may not have achieved the expected outcomes in large-scale clinical trials. THI is more than an imaging analysis tool. It quantifies the complexity of a tumor's internal structure, transforming assessment that has traditionally relied on experience into an objective, data-driven approach,” said Cai Jing, head of the Department of Health Technology and Informatics and chair professor of medical physics and intelligent oncology at PolyU.

Related Links
The Hong Kong Polytechnic University 


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Medical Examination & Procedure Light
Vega 80
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.